Related Experiment Video

Updated: Aug 29, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

[HDL-cholesterol-- active or passive participant in the pathogenesis of atherosclerosis]

R Artenie1, Didona Ungureanu, Anca Artenie

  • 1Clinica a III-a Medicală Cardiologică I. Enescu, Spitalul Clinic Judeţean de Urgenţe Sf. Spiridon Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|February 6, 2004
PubMed

Insights

High cholesterol and LDL-cholesterol contribute to atherosclerosis. Statins and fibrates effectively lower these levels and increase HDL-cholesterol, aiding atherosclerosis regression.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biochemistry

Context:

  • Elevated cholesterol and low-density lipoprotein cholesterol (LDLc) are key drivers in atherosclerosis development.
  • Hypercholesterolemia treatments, including statins and fibrates, demonstrate significant benefits for cardiovascular and atherosclerotic diseases.

Purpose:

  • To elucidate the mechanisms by which statin and fibrate therapies increase high-density lipoprotein cholesterol (HDLc).
  • To review the existing literature on HDLc-raising mechanisms associated with lipid-lowering drug classes.

Summary:

  • This review focuses on the beneficial effects of statins and fibrates in managing hypercholesterolemia and atherosclerosis.
  • A primary outcome of these treatments is the reduction of cholesterol and LDLc levels.
  • Epidemiological data indicate these therapies also elevate HDLc, a crucial factor in atherosclerotic regression.

Impact:

  • Understanding HDLc-raising mechanisms can optimize lipid-lowering strategies.
  • Enhanced HDLc may contribute significantly to the regression of atherosclerosis, improving patient outcomes.
  • This review provides insights into the multifaceted benefits of statins and fibrates beyond LDLc reduction.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...